Clinical characteristics and outcomes in patients with acute myeloid leukemia with concurrent FLT3-ITD and IDH mutations期刊界 All Journals 搜尽天下杂志传播学术成果专业期刊搜索期刊信息化学术搜索

Clinical characteristics and outcomes in patients with acute myeloid leukemia with concurrent FLT3-ITD and IDH mutations

Authors:	Mahran Shoukier MD Tapan Kadia MD Marina Konopleva MD PhD Ahmad S. Alotaibi MD Mansour Alfayez MD Sanam Loghavi MD Keyur P. Patel MD PhD Rashmi Kanagal-Shamanna MD Jorge Cortes MD Bachar Samra MD Elias Jabbour MD Guillermo Garcia-Manero MD Koichi Takahashi MD PhD Sherry Pierce RN BS BA Nicholas J. Short MD Musa Yilmaz MD Koji Sasaki MD PhD Lucia Masarova MD Naveen Pemmaraju MD Gautam Borthakur MD Hagop M. Kantarjian MD Farhad Ravandi MD Courtney D. DiNardo MD Naval Daver MD

Affiliation:	1. Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas;2. Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas;3. Georgia Cancer Center at Augusta University, Augusta, Georgia

Abstract:

Keywords:	acute myeloid leukemia FLT3 and/or IDH inhibitors FMS-like tyrosine kinase 3 (FLT3) with the internal tandem duplication (ITD) mutation isocitrate dehydrogenase (IDH) mutations